表紙
市場調查報告書
商品編碼
953963

全球非鴉片類藥物疼痛市場規模調查-按產品,應用和地區預測(2020-2027)

Global Non-Opioid Pain Treatment Market Size study, by Product, by Application and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2019年全球非鴉片類藥物疼痛治療市場的價值估計約為1380萬美元,預計在2020-2027年預測期間將以超過18%的健康增長率增長。非鴉片類藥物的疼痛治療已逐漸成為輕度至中度疼痛的補充療法。由於非鴉片類藥物的疼痛治療是非處方藥(OTC),因此可以在有或沒有處方的情況下定期服用。這種治療通常可以提供強效的止痛藥。鴉片類藥物通常會上癮,因此使用非鴉片類藥物止痛藥代替鴉片類藥物。對於急性疼痛,非鴉片類藥物是提供有效的健康益處和一線治療的理想選擇,並且還提供非處方藥和處方藥。這正在增加全球對非鴉片類藥物療法的需求。此外,在發達國家和發展中國家,諸如癌症等慢性病的患病率上升,以及與非鴉片類藥物止痛相關的研發努力也有助於預測期。是負責市場增長的因素。根據國際癌症研究機構(IARC)的數據,2018年約有1700萬新癌症病例,全球有950萬癌症死亡。根據IARC的調查,全球癌症的發病率將繼續上升,到2040年將有2750萬例新癌症病例和2036萬例癌症死亡病例。預計這將加速對非阿片類藥物疼痛治療的需求。隨著最近COVID-19在世界各地的廣泛使用,各國政府已迫使患者使用某些藥物來控制疾病和/或防止COVID-19的傳播。這可能會對非阿片類藥物止痛藥市場的增長產生積極影響。然而,在2020年至2027年的預測期內,替代療法和假冒產品的存在一直是限制市場增長的關鍵因素之一。

本報告調查了全球非鴉片類藥物疼痛治療市場,提供了該市場的概況以及按產品,應用和地區劃分的趨勢,以及進入該市場的公司的概況。

目錄

第1章執行摘要

第2章全球Nonopioid疼痛治療的市場定義和範圍

第3章非鴉片類藥物疼痛治療的全球市場動態

  • 非鴉片類藥物疼痛治療市場的影響分析(2018-2027)

第4章全球非鴉片類藥物疼痛治療市場的行業分析

  • 波特的五力模型
  • PEST分析
  • 投資招聘模型
  • 分析師的建議和結論

第5章按產品分列的全球非鴉片類疼痛治療市場

  • 市場概況
  • 全球非鴉片類藥物疼痛治療市場(按產品),性能潛力分析
  • 按產品分列的全球非鴉片類藥物疼痛治療市場估計和預測:2017-2027年(百萬美元)
  • 非鴉片類藥物疼痛治療市場,細分分析
    • 醫用大麻
    • 包括薄荷腦
    • 含Omega-3脂肪酸
    • 肉毒桿菌毒素
    • 源自辣椒素

第6章按用途分列的全球非鴉片類疼痛治療市場

  • 市場概況
  • 全球非鴉片類藥物疼痛治療市場(按性能,潛能分析)
  • 按應用分列的全球非阿片類藥物疼痛治療市場估計和預測:2017-2027年(百萬美元)
  • 非鴉片類藥物疼痛治療市場,細分分析
    • 骨科和肌肉骨骼疼痛
    • 神經性疼痛
    • 癌症疼痛
    • 其他

第7章全球非鴉片類藥物治療市場,區域分析

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 其他

第8章競爭信息

  • 頂級市場策略
  • 公司簡介
    • Medropharm Gmbh
    • US Worldmeds LLC
    • Centrexion Therapeutics Corp.
    • Tilray, Inc.
    • GW Pharmaceuticals, plc
    • Allergan plc
    • Cronos Group
    • Medical Marijuana, Inc.
    • Cara Therapeutics, Inc.
    • Canopy Growth Corporation

第9章調查過程

目錄

Title:
Global Non-Opioid Pain Treatment Market Size study, by Product (Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived), by Application (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others) and Regional Forecasts 2020-2027.

Global Non-Opioid Pain Treatment Market is valued at approximately USD 13.8 million in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027. Non-opioid pain treatment is the complementary to the opioids treatment which are increasingly used for the mild to moderate pain. Non opioids pain treatment is regularly taken with or without remedy that is over the counter (OTC) drugs. This treatment method are often robust pain relievers. They typically opt in the place of opioids due to its increase addiction triggered by opioids. For acute pain, non-opioid drugs are ideal to provide effective health benefits and first-line treatment and are available in over the counter and prescription formulations. This has led to a rise in demand for non-opioid treatment all over the world. Moreover, the increasing prevalence of chronic diseases such as cancer in the developed & developing countries, along with the rising research and developmental (R&D) efforts associated with non-opioid treatment for pain relief are few other factors responsible for the market growth over the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases were registered in 2018, with overall 9.5 million cancer deaths around the world. As per the IARC, the global prevalence of cancer is also expected to grow to over 27.5 million new cancer cases and 16.3 million cancer deaths by the year 2040. This, in turn, is expected to accelerate the demand for Non-Opioid Pain Treatment around the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of several drugs among the patients for disease management and/or to prevent the spread of COVID-19. This is likely to positively impact the growth of the non-opioid pain treatment drugs market. However, the presence for alternative therapies and counterfeit products is one of the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Non-Opioid Pain Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the undergoing clinical trials and funding for R&D of novel drug therapies, along with the presence of significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of chronic diseases, along with the changing economic demographic which improve drug affordability would create lucrative growth prospects for the Non-Opioid Pain Treatment market across the Asia-Pacific region.

Major market player included in this report are:

Medropharm Gmbh

US Worldmeds LLC

Centrexion Therapeutics Corp.

Tilray, Inc.

GW Pharmaceuticals, plc

Allergan plc

Cronos Group

Medical Marijuana, Inc.

Cara Therapeutics, Inc.

Canopy Growth Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Medical Cannabis

Menthol-Containing

Omega 3 Fatty Acid-Containing

Botulinum Toxins

Capsaicin-Derived

By Application:

Orthopaedic and Musculoskeletal Pain

Neuropathic Pain

Cancer Pain

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Non-Opioid Pain Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. Non-Opioid Pain Treatment Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. Non-Opioid Pain Treatment Market, by Product, 2018-2027 (USD Million)
    • 1.2.3. Non-Opioid Pain Treatment Market, by Application, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Non-Opioid Pain Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Non-Opioid Pain Treatment Market Dynamics

  • 3.1. Non-Opioid Pain Treatment Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Non-Opioid Pain Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Non-Opioid Pain Treatment Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Non-Opioid Pain Treatment Market by Product, Performance - Potential Analysis
  • 5.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Product 2017-2027 (USD Million)
  • 5.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
    • 5.4.1. Medical Cannabis
    • 5.4.2. Menthol-Containing
    • 5.4.3. Omega 3 Fatty Acid-Containing
    • 5.4.4. Botulinum Toxins
    • 5.4.5. Capsaicin-Derived

Chapter 6. Global Non-Opioid Pain Treatment Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Non-Opioid Pain Treatment Market by Application, Performance - Potential Analysis
  • 6.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Application 2017-2027 (USD Million)
  • 6.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
    • 6.4.1. Orthopaedic and Musculoskeletal Pain
    • 6.4.2. Neuropathic Pain
    • 6.4.3. Cancer Pain
    • 6.4.4. Others

Chapter 7. Global Non-Opioid Pain Treatment Market, Regional Analysis

  • 7.1. Non-Opioid Pain Treatment Market, Regional Market Snapshot
  • 7.2. North America Non-Opioid Pain Treatment Market
    • 7.2.1. U.S. Non-Opioid Pain Treatment Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Non-Opioid Pain Treatment Market
  • 7.3. Europe Non-Opioid Pain Treatment Market Snapshot
    • 7.3.1. U.K. Non-Opioid Pain Treatment Market
    • 7.3.2. Germany Non-Opioid Pain Treatment Market
    • 7.3.3. France Non-Opioid Pain Treatment Market
    • 7.3.4. Spain Non-Opioid Pain Treatment Market
    • 7.3.5. Italy Non-Opioid Pain Treatment Market
    • 7.3.6. Rest of Europe Non-Opioid Pain Treatment Market
  • 7.4. Asia-Pacific Non-Opioid Pain Treatment Market Snapshot
    • 7.4.1. China Non-Opioid Pain Treatment Market
    • 7.4.2. India Non-Opioid Pain Treatment Market
    • 7.4.3. Japan Non-Opioid Pain Treatment Market
    • 7.4.4. Australia Non-Opioid Pain Treatment Market
    • 7.4.5. South Korea Non-Opioid Pain Treatment Market
    • 7.4.6. Rest of Asia Pacific Non-Opioid Pain Treatment Market
  • 7.5. Latin America Non-Opioid Pain Treatment Market Snapshot
    • 7.5.1. Brazil Non-Opioid Pain Treatment Market
    • 7.5.2. Mexico Non-Opioid Pain Treatment Market
  • 7.6. Rest of The World Non-Opioid Pain Treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Medropharm Gmbh
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. US Worldmeds LLC
    • 8.2.3. Centrexion Therapeutics Corp.
    • 8.2.4. Tilray, Inc.
    • 8.2.5. GW Pharmaceuticals, plc
    • 8.2.6. Allergan plc
    • 8.2.7. Cronos Group
    • 8.2.8. Medical Marijuana, Inc.
    • 8.2.9. Cara Therapeutics, Inc.
    • 8.2.10. Canopy Growth Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Non-Opioid Pain Treatment market, report scope
  • TABLE 2. Global Non-Opioid Pain Treatment market estimates & forecasts by region 2017-2027 (USD Million)
  • TABLE 3. Global Non-Opioid Pain Treatment market estimates & forecasts by Product 2017-2027 (USD Million)
  • TABLE 4. Global Non-Opioid Pain Treatment market estimates & forecasts by Application 2017-2027 (USD Million)
  • TABLE 5. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 6. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 7. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 8. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 9. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 10. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 11. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 12. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 13. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 14. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 15. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 16. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 17. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 18. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 19. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 20. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 21. U.S. Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 22. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 23. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 24. Canada Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 25. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 26. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 27. UK Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 28. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 29. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 30. Germany Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 31. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 32. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 33. France Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 34. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 35. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 36. Spain Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 37. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 38. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 39. Italy Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 40. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 41. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 42. ROE Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 43. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 44. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 45. China Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 46. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 47. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 48. India Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 49. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 50. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 51. Japan Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 52. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 53. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 54. Australia Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 55. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 56. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 57. South Korea Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 58. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 59. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 60. ROPAC Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 61. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 62. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 63. Brazil Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 64. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 65. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 66. Mexico Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 67. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 68. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 69. ROLA Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 70. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 71. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 72. ROW Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 73. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 74. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 75. List of secondary sources, used in the study of global Non-Opioid Pain Treatment market
  • TABLE 76. List of primary sources, used in the study of global Non-Opioid Pain Treatment market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Non-Opioid Pain Treatment market, research methodology
  • FIG 2. Global Non-Opioid Pain Treatment market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Non-Opioid Pain Treatment market, key trends 2019
  • FIG 5. Global Non-Opioid Pain Treatment market, growth prospects 2020-2027
  • FIG 6. Global Non-Opioid Pain Treatment market, porters 5 force model
  • FIG 7. Global Non-Opioid Pain Treatment market, pest analysis
  • FIG 8. Global Non-Opioid Pain Treatment market, value chain analysis
  • FIG 9. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 10. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 11. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 12. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 13. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 14. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 15. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 16. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
  • FIG 17. Global Non-Opioid Pain Treatment market, regional snapshot 2017 & 2027
  • FIG 18. North America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
  • FIG 19. Europe Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
  • FIG 20. Asia-Pacific Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
  • FIG 21. Latin America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
  • FIG 22. Global Non-Opioid Pain Treatment market, company market share analysis (2019)